Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119114764 | 11911476 | 4 | F | 201303 | 20160809 | 20160112 | 20160823 | EXP | CA-VALIDUS PHARMACEUTICALS LLC-CA-2016VAL000018 | VALIDUS | 0.00 | Y | 0.00000 | 20160823 | CN | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119114764 | 11911476 | 1 | PS | METOPROLOL TARTRATE. | METOPROLOL TARTRATE | 1 | 25 MG, BID | U | 17963 | 25 | MG | ||||||||
| 119114764 | 11911476 | 2 | SS | SANDOSTATIN | OCTREOTIDE ACETATE | 1 | Intramuscular | 30 MG, QMO (EVERY 4 WEEKS) | U | 0 | 30 | MG | |||||||
| 119114764 | 11911476 | 3 | SS | SANDOSTATIN | OCTREOTIDE ACETATE | 1 | Subcutaneous | 50 ?G, ONCE/SINGLE (TEST DOSE) | 0 | 50 | UG | ||||||||
| 119114764 | 11911476 | 4 | C | GLYCERYL TRINITRATE | NITROGLYCERIN | 1 | UNK | U | 0 | PATCH |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 119114764 | 11911476 | 1 | Chest pain |
| 119114764 | 11911476 | 2 | Neuroendocrine tumour |
| 119114764 | 11911476 | 3 | Neuroendocrine tumour |
| 119114764 | 11911476 | 4 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 119114764 | 11911476 | OT |
| 119114764 | 11911476 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 119114764 | 11911476 | Abdominal pain | |
| 119114764 | 11911476 | Abnormal faeces | |
| 119114764 | 11911476 | Blood pressure diastolic decreased | |
| 119114764 | 11911476 | Blood pressure increased | |
| 119114764 | 11911476 | Blood pressure systolic increased | |
| 119114764 | 11911476 | Chest pain | |
| 119114764 | 11911476 | Diarrhoea | |
| 119114764 | 11911476 | Flatulence | |
| 119114764 | 11911476 | Gastrointestinal disorder | |
| 119114764 | 11911476 | Gout | |
| 119114764 | 11911476 | Injection site pain | |
| 119114764 | 11911476 | Myocardial infarction | |
| 119114764 | 11911476 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 119114764 | 11911476 | 2 | 20130307 | 0 | ||
| 119114764 | 11911476 | 3 | 20130307 | 20130307 | 0 |